Ii vaccine adjuvant
US-11813327-B2 · Nov 14, 2023 · US
Epstein-Barr virus
Epstein-Barr virus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/05 |
| Official title | Epstein-Barr virus |
| Display label | Epstein-Barr virus |
| Total patents | 92 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 9 |
| 2020 | 12 |
| 2021 | 14 |
| 2022 | 10 |
| 2023 | 15 |
| 2024 | 16 |
| 2025 | 3 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Polypeptide encoded by eb virus bnlf2b gene and use thereof in detection
US-2023324396-A1 · Oct 12, 2023 · US
Anti-CD25 for tumour specific cell depletion
US-11697688-B2 · Jul 11, 2023 · US
Ebv-specific immune cells
US-2022401478-A1 · Dec 22, 2022 · US
Viral Origin of Replication to Increase Protein Productivity from Mammalian Cells
US-2022363723-A1 · Nov 17, 2022 · US
Epstein-barr virus nucleic acid constructs and vaccines made therefrom, and methods of using same
US-2022354945-A1 · Nov 10, 2022 · US
Epstein-Barr virus nucleic acid constructs and vaccines made therefrom, and methods of using same
US-11395851-B2 · Jul 26, 2022 · US
Expression system for expressing herpesvirus glycoprotein complexes
US-11389529-B2 · Jul 19, 2022 · US
Recombinant baculoviruses and their uses in detecting arthropod-borne virus
US-2022196673-A1 · Jun 23, 2022 · US
Li vaccine adjuvant
US-2022105178-A1 · Apr 7, 2022 · US
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
US-2022098284-A1 · Mar 31, 2022 · US
Re-directed immunotherapy
US-11236131-B2 · Feb 1, 2022 · US
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
US-11236151-B2 · Feb 1, 2022 · US
Methods and compositions for treating cancer by targeting the clec2d-klrb1 pathway
US-2021363260-A1 · Nov 25, 2021 · US
Ii vaccine adjuvant
US-11179461-B2 · Nov 23, 2021 · US
Fg21 mutants and uses thereof
US-2021317176-A1 · Oct 14, 2021 · US
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
US-11072640-B2 · Jul 27, 2021 · US
Hepatitis c virus peptide compositions and methods of use thereof
US-2021052721-A1 · Feb 25, 2021 · US
Anti-cd25 antibody agents
US-2021054084-A1 · Feb 25, 2021 · US
Anti-cd25 for tumour specific cell depletion
US-2021047420-A1 · Feb 18, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/05?
- CPC C07K14/05 is the Cooperative Patent Classification code for “Epstein-Barr virus.”
- How many patents are filed under CPC C07K14/05 (Epstein-Barr virus)?
- Our database includes 92 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/05 growing?
- Publication counts under this code: 16 in 2024 vs 3 in 2025 (latest complete years).